三级片视频播放,精品三级片在线观看,A级性爱视频,欧美+日韩+国产+无码+小说,亲子伦XX XX熟女,秋霞最新午夜伦伦A片黑狐,韩国理伦片漂亮的保拇,一边吃奶一边做边爱完整版,欧美放荡性护士videos

上海起發實驗試劑有限公司

當前位置：首頁   >>   資料下載   >>   matriksbiotek2024年價格表-上海起發

matriksbiotek2024年價格表-上海起發

時間：2024/3/4閱讀：342
分享：

  • 提供商

    上海起發實驗試劑有限公司

  • 資料大小

    630.8KB

  • 資料圖片

  • 下載次數

    1次

  • 資料類型

    EXCEL 文檔

  • 瀏覽次數

    342次
點擊免費下載該資料

matriksbiotek2024年價格表

Matriks Biotek專門生產針對抗體藥的ELISA試劑盒，用于檢測抗體藥的體內含量或因用于產生的針對相應抗體藥的抗體的體內含量。Matriks Biotek®, SHIKARI®和KLONART®為Matriks生物技術公司注冊的產品商標。其產品達到ISO 13485 & CE IVD標準。

MatriksBiote抗體藥是一類相對新型的生物制劑。檢測抗體藥及其抗體水平在治療和個性化用藥上具有重要意義。大量的臨床和制藥公司都在致力于抗體藥物的濃度水平和療效的研究。

特別告知：為保證產品質量與良好性能，所以在購買相應產品的同時我司會收取一定量的運輸費用！！！本次報價有效時間為2024年1月8日---2024年12月14日。

貨號品名規格價格品牌貨期價格來源
ABA-FD-OREAbatacept (Orencia®) Free drug96T13541.38 matriksbiotek3-4周上海起發
ABA-QLS-OREAbatacept (Orencia®) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
ABA-QNS-OREAbatacept (Orencia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
ADA-FD-HUMAdalimumab (Humira®) Free drug96T11834.48 matriksbiotek3-4周上海起發
ADA-QLS-HUMAdalimumab (Humira®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
ADA-QNFT-HUMAdalimumab (Humira®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
ADA-QNS-HUMAdalimumab (Humira®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
ADA-SPEC-ADAAdalimumab (Humira®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發
AFL-FD-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發
AFL-FD-SENS-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發
AFL-QLS-EYLAflibercept (Eylea®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
AFL-QNS-EYLAflibercept (Eylea®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
ATE-FD-TECAtezolizumab (Tecentriq®) Free drug96T12289.66 matriksbiotek3-4周上海起發
ATE-QLS-TECAtezolizumab (Tecentriq®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
BEV-FD-AABevacizumab (Avastin®) Free drug96T11834.48 matriksbiotek3-4周上海起發
CAN-FD-ILACanakinumab (Ilaris®) Free drug96T12289.66 matriksbiotek3-4周上海起發
CAN-QLS-ILACanakinumab (Ilaris®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
CAN-QNS-ILACanakinumab (Ilaris®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
DAR-FD-DARDaratumumab (Darzalex®) Free drug96T12289.66 matriksbiotek3-4周上海起發
DAR-QLS-DARDaratumumab (Darzalex®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
DEN-QNS-PRODenosumab (Prolia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
DUR-FD-IMFDurvalumab (Imfinzi®) Free drug96T12289.66 matriksbiotek3-4周上海起發
DUR-QLS-IMFDurvalumab (Imfinzi®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
ETA-FD-ENBEtanercept (Enbrel®) Free drug96T11834.48 matriksbiotek3-4周上海起發
EVO-FD-REPEvolocumab (Repatha® ) Free drug96T13541.38 matriksbiotek3-4周上海起發
EVO-QLS-REPEvolocumab (Repatha® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
INF-FD-REMIInfliximab (Remicade®) Free drug96T11834.48 matriksbiotek3-4周上海起發
INF-FD-REMSInfliximab (Remsima®) Free drug96T11834.48 matriksbiotek3-4周上海起發
INF-QLS-REMIInfliximab (Remicade®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
INF-QLS-REMSInfliximab (Remsima®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
INF-QNFT-REMIInfliximab (Remicade®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNFT-REMSInfliximab (Remsima®) Antibody screening - Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNS-REMIInfliximab (Remicade®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNS-REMSInfliximab (Remsima®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
INF-SPEC-INFInfliximab (Remicade®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發
NIV-FD-OPDNivolumab (Opdivo®) Free drug96T12289.66 matriksbiotek3-4周上海起發
PAL-FD-SYNPalivizumab (Synagis® ) Free drug96T13541.38 matriksbiotek3-4周上海起發
PAL-QLS-SYNPalivizumab (Synagis® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
PAL-QNS-SYNPalivizumab (Synagis® ) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
PEM-FD-KEYPembrolizumab (Keytruda®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RAN-FD-LUCRanibizumab (Lucentis®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RIT-FD-RMRituximab (Rituxan®, Mabthera®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RIT-QLS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
RIT-QNS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
SEC-FD-VERSecukinumab (Cosentyx® , Verxant®) Free drug96T12289.66 matriksbiotek3-4周上海起發
SEC-QLS-VERSecukinumab (Cosentyx® , Verxant®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
TOC-QNS-ACTTocilizumab (Actemra®) Antibody screening - Quantitative96T11834.48 matriksbiotek3-4周上海起發
TRA-FD-HHTrastuzumab (Herceptin®, Herclon®) Free drug96T11834.48 matriksbiotek3-4周上海起發
UST-QLS-STEUstekinumab (Stelara®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
VED-FD-ENTVedolizumab (Entyvio®) Free drug96T12289.66 matriksbiotek3-4周上海起發
VED-QLS-ENTVedolizumab (Entyvio®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發


（*此為部分產品價格完整價格請下載文件）


關鍵詞：matriksbiotek、Matriks Biotek®、KLONART®、SHIKARI®、ELISA試劑盒

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏！
標簽：
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用：

提示

X
您的留言已提交成功！我們將在第一時間回復您~

以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。

溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。

撥打電話
在線留言
主站蜘蛛池模板： 房山区| 威海市| 四子王旗| 古蔺县| 庄浪县| 南华县| 正蓝旗| 岑溪市| 紫阳县| 仁布县| 高安市| 隆尧县| 吴江市| 永登县| 乌兰浩特市| 宁津县| 长泰县| 鹤庆县| 确山县| 株洲县| 漠河县| 秦安县| 犍为县| 永靖县| 东乌珠穆沁旗| 阳江市| 木里| 西乌| 分宜县| 万山特区| 彭水| 六枝特区| 文成县| 长葛市| 英德市| 五家渠市| 阿巴嘎旗| 威信县| 砀山县| 阳信县| 怀宁县|